Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug may help men avoid catheters after ear, nose, and throat surgery

NCT ID NCT06398899

Symptom relief Sponsor: National Taiwan University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested two drugs used to reverse muscle relaxants after surgery: sugammadex and a combination of neostigmine and glycopyrrolate. The goal was to see which one better prevents urinary retention in 124 patients having ear, nose, or throat surgery who were at high risk due to prior urinary issues, enlarged prostate, or prostate cancer. The researchers wanted to find out if sugammadex causes fewer problems with urination after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
sugammadex injection (Bridion) and neostigmine/glycopyrrolate injection
What this could lead to
If sugammadex works better, it could offer a safer way to reverse muscle relaxants after surgery, reducing the need for catheters in patients at risk of urinary retention.
What could go wrong
This is a small, completed study with 124 patients, so results may not apply to everyone. The benefit over standard care may be modest, and individual responses can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

124 people

The number who actually took part.

Started

May 2024

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ENT surgery patients whose surgery is expected to take less than three hours and no planned Foley catheter * high risk of postoperative urinary retention, including * prior history of postoperative urinary retention * benign prostatic hypertrophy * history of prostate cancer Exclusion Criteria: * refusal or inability to provide informed consent * age younger than 18 years * American Society of Anesthesiologists class more than III * pregnancy * impaired renal function (creatinine clearance \< 30 mL/min) * allergy to a study drug

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Benign prostatic hypertrophy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia chronic otitis media chronic rhinosinusitis laryngeal disorder prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic otitis media Chronic sinusitis Head and neck surgery Laryngeal disease

Contacts and locations

Locations

  • National Taiwan University Hospital

    Taipei, 100, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.